The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs

<div>(a) Pooled analysis of objective response rate (ORR) comparing the application of ramucirumab (RAM) alone or plus chemotherapy with the control (placebo or chemotherapy). (b) Pooled analysis of ORR comparing the application of RAM alone or plus chemotherapy with chemotherapy.</div>

Gastroenterology Research and Practice

fig4

Figure 4

Figure 4: The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs 